You are here: Industry Insights > acquisition

News List

Philip Morris agrees to acquire Vectura for $1.45bn pharmaceutical-technology
July 13, 2021
Philip Morris International (PMI) has made an offer to acquire a contract development and manufacturing organisation (CDMO), Vectura Group, for approximately $1.45bn (£1.045bn) to boost its product pipeline development expertise in inhaled treatments.
AstraZeneca receives EC approval for $39bn Alexion acquisition pharmaceutical-technology
July 07, 2021
The European Commission has cleared the proposed acquisition by AstraZeneca of US-based biopharmaceutical company Alexion Pharmaceuticals for approximately $39bn or $175 a share.
Philip Morris to acquire Fertin Pharma for $812.8m pharmaceutical-business-review
July 02, 2021
Philip Morris International has signed an agreement to acquire Fertin Pharma from private equity firm EQT for approximately $812.8m (DKK5.1bn).
Piramal Pharma completes acquisition of Hemmo Pharmaceuticals expresspharma
June 24, 2021
Piramal Pharma has completed the acquisition of Hemmo Pharmaceuticals, according to a statement released by the company.
Danaher To Acquire Aldevron for $9.6B contractpharma
June 22, 2021
Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.
Solvias Acquires Chemic Labs contractpharma
June 21, 2021
Solvias, an analytical testing, contract research, development and manufacturing company, has acquired Chemic Laboratories, Inc. based in Canton, MA.
Premier Research Acquires Camargo Pharmaceutical Services contractpharma
May 24, 2021
Premier Research has acquired Camargo Pharmaceutical Services based in Cincinnati, OH.
CD&R to acquire UDG Healthcare for $3.7bn pharmaceutical-technology
May 14, 2021
Private equity firm Clayton, Dubilier & Rice (CD&R) has agreed to acquire Ireland-based UDG Healthcare for a total of $3.7bn (£2.6bn) in cash.
Emmes Acquires Orphan Reach contractpharma
May 13, 2021
Emmes, a global, full-service CRO, has acquired Orphan Reach, a company headquartered in the UK with offices in Ireland, Germany, India, Canada, and the U.S., dedicated to clinical research in rare diseases.
AstraZeneca Shareholders Approve Proposed Acquisition of Alexion americanpharmaceuticalreview
May 12, 2021
A requisite majority of AstraZeneca shareholders has approved the proposal to acquire the entire common stock of Alexion Pharmaceuticals, Inc. (Alexion) at a general meeting.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page